Metraipolis › archive › dc_0946fcf8aa17

Signaling pathways and advances in targeted therapy for adenomyosis — Europe PMC PMID:41278208

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41278208
DOI
10.3389/fcell.2025.1685525
License (as archived)
solo-consultazione
Archived
2026-11-08T18:22:56.759Z
SHA-256 of the archived text
699b4ea513e9757e78c5353cc860ff999c0fcbde3bad55a422bf72402395c9c5
Stable URL of this page
https://metraipolis.com/documento/dc_0946fcf8aa17

How to cite

Signaling pathways and advances in targeted therapy for adenomyosis — Europe PMC PMID:41278208 — Europe PMC (en), https://europepmc.org/article/MED/41278208 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0946fcf8aa17 (Metraipolis archive dc_0946fcf8aa17, sha256 699b4ea513e9757e78c5353cc860ff999c0fcbde3bad55a422bf72402395c9c5)
BibTeX
@misc{dc0946fcf8aa17,
  title = {Signaling pathways and advances in targeted therapy for adenomyosis — Europe PMC PMID:41278208},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41278208},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0946fcf8aa17; sha256 699b4ea513e9757e78c5353cc860ff999c0fcbde3bad55a422bf72402395c9c5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41278208. Agents can read the archived copy with the MCP tool read_document.